AAAAAA
Results: 1-25/33
Authors:
STUBBS P
SEED M
LANE D
COLLINSON P
KENDALL F
NOBLE M
Citation: P. Stubbs et al., LIPOPROTEIN(A) AS A RISK PREDICTOR FOR CARDIAC MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES, European heart journal, 19(9), 1998, pp. 1355-1364
Authors:
MISRA M
COOPER C
REAVELEY D
OCONNOR B
SEED M
BROWN E
Citation: M. Misra et al., CATABOLISM OF LIPOPROTEIN (A) [LP(A)] IN PATIENTS ON DIALYSIS, Journal of the American Society of Nephrology, 8, 1997, pp. 2909-2909
Authors:
MISRA M
REAVELEY DA
ASHWORTH J
MULLER B
SEED M
BROWN EA
Citation: M. Misra et al., 6-MONTH PROSPECTIVE CROSS-OVER STUDY TO DETERMINE THE EFFECTS OF 1.1-PERCENT AMINO-ACID DIALYSATE ON LIPID-METABOLISM IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS, Peritoneal dialysis international, 17(3), 1997, pp. 279-286
Authors:
STUBBS P
SEED M
MOSELEY D
OCONNOR B
COLLINSON P
NOBLE M
Citation: P. Stubbs et al., A PROSPECTIVE-STUDY OF THE ROLE OF LIPOPROTEIN(A) IN THE PATHOGENESISOF UNSTABLE ANGINA, European heart journal, 18(4), 1997, pp. 603-607
Authors:
MISRA M
REAVELEY DA
SEED M
BROWN EA
Citation: M. Misra et al., CARDIOVASCULAR EVENTS ON DIALYSIS - A PROSPECTIVE ANALYSIS OF LIPOPROTEIN (A) [LP(A)] AND OTHER RISK-FACTORS, Kidney international, 52(1), 1997, pp. 267-268
Authors:
WIGHT CO
SEED M
YEO WW
MCCULLOCH TA
Citation: Co. Wight et al., GASTRIC OUTFLOW OBSTRUCTION CAUSED BY GALL-STONES AND LEADING TO DEATH BY COMPLEX METABOLIC DERANGEMENT, Journal of Clinical Pathology, 50(11), 1997, pp. 963-965
Authors:
SEED M
JONES L
MCCLAREN M
Citation: M. Seed et al., THE IMPACT OF HRT ON SELECTED VASCULAR AND METABOLIC RISK-FACTORS FORATHEROSCLEROSIS, Atherosclerosis, 134(1-2), 1997, pp. 113-113
Authors:
JONES L
SEED M
HEATH K
GUDNASON V
HUMPHRIES SE
Citation: L. Jones et al., IS THERE AN EFFECT OF DEFINED MOLECULAR DEFECT ON THERAPEUTIC RESPONSE TO HMG CO-A REDUCTASE INHIBITORS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 134(1-2), 1997, pp. 126-126
Authors:
SEED M
Citation: M. Seed, DOUBLE-BLIND COMPARISON OF THE QUALITY-OF-LIFE OF HYPERCHOLESTEROLEMIC PATIENTS TREATED WITH SIMVASTATIN OR PRAVASTATIN, Atherosclerosis, 130, 1997, pp. 25-25
Authors:
PAPWORTH J
COLVILLENASH P
ALAM C
SEED M
WILLOUGHBY D
Citation: J. Papworth et al., THE DEPLETION OF SUBSTANCE-P BY DICLOFENAC IN THE MOUSE, European journal of pharmacology, 325(2-3), 1997, pp. 1-2
Authors:
STUBBS P
SEED M
COLLINSON P
OCONNOR B
MOSELEY D
NOBLE MIM
Citation: P. Stubbs et al., THE ROLE OF LIPOPROTEIN(A) IN THE PATHOGENESIS OF UNSTABLE ANGINA, HEART, 75(5), 1996, pp. 34-34
Authors:
STUBBS P
COLLINSON P
KENDALL F
NOBIE M
SEED M
Citation: P. Stubbs et al., THE PROGNOSTIC-SIGNIFICANCE OF LIPOPROTEIN(A) CONCENTRATIONS FOLLOWING MYOCARDIAL-INFARCTION, HEART, 75(5), 1996, pp. 249-249
Authors:
WHEELER DC
MORGAN R
THOMAS DM
SEED M
REES A
MOORE RH
Citation: Dc. Wheeler et al., FACTORS INFLUENCING PLASMA-LIPID PROFILES INCLUDING LIPOPROTEIN (A) CONCENTRATIONS IN RENAL-TRANSPLANT RECIPIENTS, Transplant international, 9(3), 1996, pp. 221-226
Authors:
PROUDLER AJ
GODSLAND IF
BRUCE R
SEED M
WYNN V
Citation: Aj. Proudler et al., LIPID AND CARBOHYDRATE METABOLIC RISK MARKERS FOR CORONARY HEART-DISEASE AND BLOOD-PRESSURE IN HEALTHY NONOBESE PREMENOPAUSAL WOMEN OF DIFFERENT RACIAL ORIGINS IN THE UNITED-KINGDOM, Metabolism, clinical and experimental, 45(3), 1996, pp. 328-333
Authors:
MAILLY F
TUGRUL Y
REYMER PWA
BRUIN T
SEED M
GROENEMEYER BF
ASPLUNDCARLSON A
VALLANCE D
WINDER AF
MILLER GJ
KASTELEIN JJP
HAMSTEN A
OLIVECRONA G
HUMPHRIES SE
TALMUD PJ
Citation: F. Mailly et al., A COMMON VARIANT IN THE GENE FOR LIPOPROTEIN-LIPASE (ASP9-]ASN) FUNCTIONAL IMPLICATIONS AND PREVALENCE IN NORMAL AND HYPERLIPIDEMIC SUBJECTS, Arteriosclerosis, thrombosis, and vascular biology, 15(4), 1995, pp. 468-478
Authors:
MISRA M
REAVELEY D
SEED M
BROWN E
Citation: M. Misra et al., SERUM-LIPOPROTEIN (A) IN ESRF - EFFECT OF DIALYSIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 584-584
Authors:
WEBB AT
REAVELEY DA
ODONNELL M
OCONNOR B
SEED M
BROWN EA
Citation: At. Webb et al., LIPIDS AND LIPOPROTEIN(A) AS RISK-FACTORS FOR VASCULAR-DISEASE IN PATIENTS ON RENAL REPLACEMENT THERAPY, Nephrology, dialysis, transplantation, 10(3), 1995, pp. 354-357
Authors:
FISHER RM
MAILLY F
PEACOCK RE
HAMSTEN A
SEED M
YUDKIN JS
BEISIEGEL U
FEUSSNER G
MILLER G
HUMPHRIES SE
TALMUD PJ
Citation: Rm. Fisher et al., INTERACTION OF THE LIPOPROTEIN-LIPASE ASPARAGINE-291-]SERINE MUTATIONWITH BODY-MASS INDEX DETERMINES ELEVATED PLASMA TRIACYLGLYCEROL CONCENTRATIONS - A STUDY IN HYPERLIPIDEMIC SUBJECTS, MYOCARDIAL-INFARCTION SURVIVORS, AND HEALTHY-ADULTS, Journal of lipid research, 36(10), 1995, pp. 2104-2112
Authors:
MADHUKAR M
WEBB A
REAVELEY D
OCONNOR B
ODONNELL M
SEED M
BROWN E
Citation: M. Madhukar et al., THE EFFECT OF CHANGE OF RENAL REPLACEMENT THERAPY ON PLASMA-LIPOPROTEIN (A) CONCENTRATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 498-498
Authors:
LINDAHL G
MAILLY F
HUMPHRIES S
SEED M
Citation: G. Lindahl et al., APOLIPOPROTEIN-E PHENOTYPE AND LIPOPROTEIN(A) IN FAMILIAL HYPERCHOLESTEROLEMIA - IMPLICATION FOR LIPOPROTEIN(A) METABOLISM, The Clinical investigator, 72(8), 1994, pp. 631-638
Authors:
SEED M
MAILLY F
VALLANCE D
DOHERTY E
WINDER A
TALMUD P
HUMPHRIES SE
Citation: M. Seed et al., LIPOPROTEIN-LIPASE ACTIVITY IN PATIENTS WITH COMBINED HYPERLIPEMIA, The Clinical investigator, 72(2), 1994, pp. 100-106
Authors:
SEED M
Citation: M. Seed, POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY, CORONARY HEART-DISEASE AND PLASMA-LIPOPROTEINS, Drugs, 47, 1994, pp. 25-34
Authors:
CLARKSON TB
HAVEL RJ
KAFONEK S",FARGER,"SEED M
SHEPHERD J
STEVENSON J
PETERS T
Citation: Tb. Clarkson et al., HORMONE REPLACEMENT AND CARDIOVASCULAR RISK-FACTORS, Drugs, 47, 1994, pp. 52-53
Authors:
KAFONEK S
LEITERSDORF E
SEED M
HAVEL RJ
BAGGIO G
PETERS T
Citation: S. Kafonek et al., FLUVASTATIN USE IN WOMEN - DISCUSSION, Drugs, 47, 1994, pp. 73-74
Authors:
HAVEL RJ
CLARKSON TB
STEVENSON J
SEED M
PETERS T
Citation: Rj. Havel et al., TREATMENT OF LIPOPROTEIN DISORDERS IN WOMEN - PROCEEDINGS OF A WORKSHOP HELD IN FRANKFURT, OCTOBER 8-9, 1993 - ROUND-TABLE DISCUSSION, Drugs, 47, 1994, pp. 75-76